Prevalence of QTc Prolongation in Patients with Parkinson’s Disease. Assessment of the Effects of Drugs, Clinical Risk Factors and Used Correction Formula

Background: Parkinson’s disease (PD) is a possible risk factor for corrected QT interval (QTc) prolongation. PD patients frequently take QTc-prolonging drugs. The aim of the study was to assess the prevalence of QTc prolongation in PD and the influence of drugs and other potential risk factors on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Malkiewicz, Jakub J., Malkiewicz, Maciej, Siuda, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037693/
https://www.ncbi.nlm.nih.gov/pubmed/33807236
http://dx.doi.org/10.3390/jcm10071396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037693/
https://www.ncbi.nlm.nih.gov/pubmed/33807236
http://dx.doi.org/10.3390/jcm10071396

Ejemplares similares